FindTrial
Sign In

A study to compare whether using a combination of steroid cream and Moisturizing Lotion is better than using only Steroid cream in humans with Dry itchy skin.

A monocentric, 2 group, single blind, randomized study to evaluate the efficacy of use of a regime combining a topical steroid and Moisturizing Lotion as compared to use of only Topical Steroid on human participants with Atopic Dermatitis/ Eczema - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/09/094165
Enrollment
34
Registered
2025-09-03
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: AD Moisturizing Lotion: Group 2: Sufficient quantity of Betnovate cream (as directed by Investigator) will be applied on affected sites, twice daily- morning and night before bedtime f

Sponsors

Lifeon Labs Pvt. Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Voluntary men and or women between 18 and 60 years of age, with mild to moderate Eczema or Atopic Dermatitis. 2. Willing to sign the Informed consent document after having the study explained to them and reading the Informed consent document 3. Cooperating to comply with protocol procedures and treatments, after being informed of the need and duration of the examinations or treatments.

Exclusion criteria

Exclusion criteria: 1. Pregnant women, Lactating mothers. 2. Participants with Eczema or Atopic Dermatitis on face 3. Participants on treatment for Eczema or Atopic Dermatitis 4. Chronic illness which may influence the study results. 5. Any clinically significant systemic or cutaneous disease, which may interfere with study treatments or procedures. 6. Participants on any medical treatment either systemic or topical which may interfere with the performance of the study treatment (presently or in the past 1 month). 7. Localized psoriasis patients.

Design outcomes

Primary

MeasureTime frame
1. EASI score (Baseline, day 7, Day 21). 2. Skin Hydration Measurement of Stratum corneum using MoistureMeter SC (Baseline, 5 mins, 1 hour, day 7, Day 21) 3. Trans epidermal water loss by VapoMeter (Baseline, 5 mins, 1 hour, day 7, Day 21) 4. Self-assessment questionnaire for efficacy (day 7, Day 21). 5. Self-assessment of reduction in itching (Baseline, 5 mins, 1 hour, day 7, Day 21) 6. Self-assessment in overall improvement in the quality of life (Baseline, day 7, Day 21) Timepoint: Day 0, 1 hour, day 7, day 21—

Secondary

MeasureTime frame
1. Clinical evaluation for skin tolerance (1 hour, day 7, Day 21). 2. Self-assessment questionnaire for skin tolerance (1 hour day 7, Day 21). Timepoint: Day 0, 1 hour, day 7, day 21—

Countries

India

Contacts

Public ContactMs Preetha Paul

Clinical Aesthetics and Investigative Management Service Pvt. Ltd. (C.L.A.I.M.S.PVT.LTD.

preetha@claimsclinical.com66758851

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026